vimarsana.com

Latest Breaking News On - Baseline patient - Page 1 : vimarsana.com

Higher T-Cell Inflamed GEP Values Are Positively Associated with Outcomes For Pembrolizumab/Axitinib in ccRCC

Higher T-cell inflamed GEP values were positively associated with clinical outcomes for pembrolizumab plus axitinib in advanced clear cell RCC.

United-states
Tennessee
America
Brian-rini
International-metastatic
Vanderbilt-ingram-cancer-center
Ingram-professor-of-cancer-research
Database-consortium
Highert-cell
Clinical-trials
Ingram-professor
Cancer-research

Tiragolumab Plus Atezolizumab and Chemotherapy Offers Survival Benefit Over Chemotherapy Alone in ESCC

Tiragolumab plus atezolizumab and chemotherapy led to significant survival improvements vs chemotherapy in patients with esophageal squamous cell carcinoma.

South-korea
Taiwan
China
Thailand
Hong-kong
Baseline-patient
Secondary-end-points
2024-gastrointestinal-cancers-symposium
Asco-gi
Nct04540211
Esophageal-squamous-cell-carcinoma

New Data Show Patients Treated with First-in-Class TREMFYA® (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from Phase 3 studies demonstrating patients treated with.

Canada
Washington
United-states
Japan
University-of-washington
Spring-house
British-columbia
Horsham
Saskatchewan
Seattle
Donvitot-creakyjoints
Terence-rooney

Patients with chronic liver disease & intractable pruritus

Nalfurafine capsules 2.5 μg, oral dispersing tablets 2.5 μg) in 1,186 patients with chronic liver disease and intractable pruritus.

Japan
Japanese
Nalfurafine-remitch
Toray-industries-inc
Japanese-ministry-of-health
Administration-child
Japanese-pharmaceutical-affairs-law
Research-laboratories-of-toray-industries-inc
Drug-use
Pharmaceutical-research-laboratories
Toray-industries
Visual-analog-scale

vimarsana © 2020. All Rights Reserved.